Record growth masks margin compression and deceleration ahead
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Q2 numbers matched guidance closely (₹1,556 Cr vs ₹1,555.5 delivered). EBITDA margin guidance (prior 15.1%) not formally lowered but compressed to 14.7%, margin recovery dependent on assumption.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Lumax delivered 35% revenue growth and 50% PAT growth in Q2, exceeding many expectations, driven by Mechatronics momentum and strong order visibility. However, EBITDA margin compressed 20 bps QoQ to 14.7% despite pricing actions, and management guided H2 growth to 15–20% (decelerating from H1's 34%), signalling cost inflation absorption challenges and demand moderation. Long-term 20% CAGR to ₹11,000 Cr has concrete capex backing (₹300 Cr FY27, new Mechatronics plant, Greenfield), but near-term margin recovery is uncertain and LIL/Aftermarket remain soft.
₹1555.5 Cr
Revenue · +34.5% YoY₹116.7 Cr
Reported PAT · +50.4% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 FY27 revenue ₹1,556 Cr, up 35% YoY
METDelivered ₹1,555.5 Cr, up 34.5% YoY
Q2 PAT ₹117 Cr, up 50% YoY
METDelivered ₹116.7 Cr, up 50.4% YoY
Q2 EBITDA ₹228 Cr at 14.7% margin, stable QoQ
OVERSTATEDQ2 reported OPM 13.5%, NPM 7.4%; Q1 margin 14.9%, implies QoQ decline
Aftermarket grew 9% YoY in H1
METAftermarket revenue H1 FY27 ₹234 Cr vs H1 FY26 ₹216 Cr = 8.3% growth, below historical pace
H2 FY27 growth expected 15–20% YoY
UnverifiedImplied guidance, lower than H1 34% delivered; suggests deceleration ahead
Earnings quality
What changed since the last call
Mechatronics acceleration & new plant capex
UpgradePrior call: Mechatronics 22% EBITDA contribution. Now: 27% of order book, ₹150 Cr new plant capex approved for Manesar. Expected ₹500 Cr post-commission revenue at scale, vs implied ₹1,000–1,100 Cr by FY31 (material upgrade in scale ambition).
Margin guidance QoQ compression
DowngradePrior Q1 call: 15.1% EBITDA margin guidance. Q2 delivered 14.7%, down 20 bps QoQ. Management reaffirmed 14.7% is 'broadly stable' but H2 margin recovery assumed, not proven.
H2 revenue growth deceleration guidance
DowngradeH1 delivered 34% growth; management guided H2 to 15–20% YoY growth, a significant moderation, citing higher base and macro headwinds.
Aftermarket growth weakness
DowngradeAftermarket 9% growth in H1 vs prior double-digit growth. Input costs and demand softness cited; management expects 'modest improvement' but 15–20% growth target (not 20%+ prior expectation).
The Q&A
Analysts pressed hard on guidance revision (Amit Hiranandani: 'Are we revising upward after 34% growth?'). Management held firm: 20–25% FY27 full-year growth, no upward revision. Several probed margin sustainability and timing of cost recovery (Raksha Srivastava, Apurva Mehta); management detailed max 1-quarter lag and claimed confidence in full recovery. Deep Shah questioned North Star guidance consistency; management clarified FY25 base and reaffirmed 20% CAGR achievable organically. Overall, management held guidance despite strong delivery, suggesting cautious outlook on sustainability.
Guidance revision post-growth — Amit Hiranandani, PhillipCapital
DodgedNo, we expect full-year 20–25% growth (₹6,000 Cr implied). H1 25% growth, H2 will moderate due to higher base from FY26.
Mechatronics content per vehicle — Radha, Motilal Oswal
PartialCurrently ₹70,000–₹75,000 per PV across product portfolio. Expected to grow by ~10% over 2–3 years as new products scale.
Cost pass-through timing — Raksha Srivastava, Narnolia Financial Services
AnsweredMost recoveries happen same quarter or max 1Q lag. Showing 30–40 bps margin dilution due to lag. Confident to recover in subsequent quarters.
North Star CAGR guidance clarity — Deep Shah, New Vernon Capital
Answered20% CAGR is from FY25 base. For FY27, 20–25% expected. Industry growing 12–15%; we outperform. If we inorganic, CAGR exceeds 20%.
Mechatronics margin trajectory — Apurva Mehta, AM Investments
AnsweredMechatronics margins currently in line with Lumax overall (14–15%). Long-term aspiration 15–18% as scale reaches critical mass and fixed costs absorb.
BCM orders and OEM identity — Amit Hiranandani, PhillipCapital
Partial₹250 Cr order book locked. Technology from large Japanese auto-component maker (not OEM). Standalone revenue, all profitability stays with Lumax.
Guidance
FY27 full-year: 20–25% YoY growth expected (from implied ₹6,000 Cr base of FY26 ₹5,000 Cr)
MediumH1 delivered 34% growth; H2 expected 15–20% due to higher comparison base and macro uncertainty. Management guided to 20–25% at year start.
H2 FY27: 15–20% YoY growth (moderation from H1 34%)
MediumHigher base from FY26 H2 growth; supply-chain inflation expected to persist; demand momentum will be key monitor.
FY31 (long-term): ₹11,000 Cr revenue (20% CAGR from FY25 base of ~₹3,000 Cr)
LowAspiration target. Requires 20% CAGR for 6 years; dependent on organic growth (claimed 15% achievable) plus inorganic (5–7% assumed).
FY27: EBITDA margin ~14.7% (no formal revised guidance, but QoQ showed 14.9% → 14.7% compression)
MediumPrior call guided 15.1%; current quarter 14.7%. Margin recovery dependent on assumption of full cost pass-through to OEMs in subsequent quarters.
FY28: Absolute EBITDA ₹1,000 Cr (implies ~15% margin if 6,500–6,700 Cr revenue assumed)
MediumManagement confident of FY28 EBITDA guidance. Margin recovery in FY28 contingent on cost stability and Mechatronics scaling.
Long-term (FY31): Target ~20% EBITDA margin (range 17–20% mentioned)
LowAspiration. Requires structural margin expansion as Mechatronics and high-margin new products scale (BCM, EV components). No binding commitment.
FY27 capex: ₹300 Cr (H1 ₹60 Cr incurred; remaining ₹240 Cr in H2)
HighAllocation: Mechatronics Manesar plant (~₹150 Cr), Greenfield Nashik ferrule-less expansion, IAC capacity.
Risks the call surfaced
Margin recovery timing
HighEBITDA margin compressed 20 bps QoQ (14.9% to 14.7%) despite claimed cost pass-through. Management cites max 1Q lag, but recovery unproven. If delayed beyond Q3, full-year margin guidance at risk.
Customer concentration
HighAdvanced Plastics is 44% of ₹1,879 Cr order book. OEM concentration risk (passenger vehicle segment). If PV demand slows or a major OEM reduces orders, material revenue impact.
Aftermarket demand softness
MediumAftermarket grew only 9% in H1 FY27 vs prior double-digit growth. Input cost headwinds and softening replacement demand cited. If trend persists, will weigh on overall growth and profitability.
Mechatronics execution risk
Medium₹150 Cr capex approved for new Manesar Mechatronics plant; SOP expected H2 FY28 with ₹500 Cr peak revenue potential. Delays or cost overruns could derail FY28–FY29 revenue and margin targets.
EV product strategy uncertainty
MediumEV component strategy narrowed to 3–5 product categories. No major OEM wins or confirmed orders disclosed. If market adoption slower than expected or competition intense, revenue ramp could be delayed.
Management
Score 7/10. Clear on strategy and numbers; transparent on segment performance and challenges (Aftermarket weakness, cost pressures). Evasive on BCM partner identity and BCM product details. Some deflection when pressed on guidance upward revisions. Strong H1 FY27 delivery: 34% revenue growth, 50% PAT growth. Guided FY27 to 20–25%, implying moderation. FY28 ₹1,000 Cr EBITDA target stated with confidence but unproven. Margin recovery track record weak (14.7% vs 15.1% prior guidance).
1 · Q3 FY27
Greenfuel ferrule-less tubes production ramp for Mahindra/Maruti CNG vehicles
2 · H2 FY28
Mechatronics Manesar plant SOP; BCM (Body Control Module) production scale-up from Japanese partner
3 · FY28
FY28 EBITDA ₹1,000 Cr (absolute) guidance to be tested; margin recovery assumption
Long-term 20% CAGR to ₹11,000 Cr has concrete capex backing (₹300 Cr FY27, new Mechatronics plant, Greenfield), but near-term margin recovery is uncertain and LIL/Aftermarket remain soft.
Informational and educational content only. Not investment advice.